title: [Prevention and treatment of traveler's diarrhea].
abstract: Travelers' diarrhea (TD) affects 20-50 per cent of individuals going to developing countries in Asia, Africa, or Latin America. The etiology varies but is dominated by enterotoxigenic E. coli, found in 30-50 per cent. TD is usually a mild disease, self-limiting in 3-4 days, but 10 per cent of those afflicted have symptoms for one week or more. Prophylaxis of TD involves dietary restrictions and, in selected medical risk groups, antimicrobial drugs. The most important treatment of TD is oral rehydration and loperamide in mild to moderate, non-invasive illness. Antibiotics for self-treatment shall be restricted for medical risk groups and individuals travelling far from medical service.
authors.affiliation: Infektionskliniken, Huddinge sjukhus.
authors.forename: B
authors.initials: B
authors.lastname: Svenungsson
authors.forename: M
authors.initials: M
authors.lastname: Jertborn
authors.forename: J
authors.initials: J
authors.lastname: Wiström
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003906:Developing Countries; D003967:Diarrhea / Q000209:etiology / Q000517:prevention & control*; D004032:Diet; D006801:Humans; D008139:Loperamide / Q000627:therapeutic use; D012307:Risk Factors; D014195:Travel
chemical_list: D000900:Anti-Bacterial Agents; D008139:Loperamide
vernacular_title: Profylax och behandling vid turistdiarré.